DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Sun Pharma Advanced Research Company Limited — Board Meeting Intimation

NSE 2 hrs ago·3 Aug 2026, 9:23 am

Sun Pharma Advanced Research Company

Sun Pharma Advanced Research Company Limited (SPARC) has announced that its board will meet on August 10, 2026, to review and approve its unaudited financial results for the quarter ending June 2026. This is a standard corporate procedure where the board formally accepts the company's financial performance for the period.

For investors, this update is significant as it provides the first official glimpse into SPARC's business health during the second quarter of the fiscal year. The results will likely reveal the company's revenue growth, profitability, and operational efficiency, offering key insights into its current market position and future trajectory.

Investors should watch for the company's commentary on its research pipeline and any guidance provided regarding upcoming projects. The release of these results will be the primary trigger for any short-term price movement in the stock.